Align Technology recently announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align’s common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock¹.
“This purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investments to drive growth and continuing to invest with discipline in the areas that will define our future,” said Joe Hogan, president and CEO. “We are excited about our next-generation technologies and treatment platforms that meet today’s patient expectations for fast, effective, and personalized treatment while also providing value and growth opportunities for our doctor customers. We believe that these innovations are not only improving outcomes in Invisalign practices but also expanding our addressable market and strengthening our competitive differentiation.”
Continued Hogan, “While we believe that the macroeconomic uncertainty will likely persist into the near future, we are confident in our ability to adapt and lead. Our long-term strategic initiatives and opportunities remain intact, as does our commitment to focused execution on transforming treatment for doctors and patients.”
About Align Technology
Align Technology designs and manufactures the Invisalign System, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 286.4 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
Source: www.invisalign.com
News 28 August 2026
(6699.HK) (“Angel”) http://www.angelaligner.com said recently that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People’s Court (Jinan City, China)
Over six years, Align has contributed more than $2M to Operation Smile’s student programs to send the next generation of global health advocates to the world stage.
Products 01 July 2026
Align, Contour, and Infiltrate: A Digital-First Approach to Minimally Invasive Smile Enhancement
This case report presents a comprehensive smile enhancement in a 24-year-old female patient whose chief concern was, “I want a beautiful smile.” Clinical examination revealed mild
News 01 July 2026
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exoca
News 05 June 2026
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
Edra Professional Books 29 August 2026
The Vertical Dimension in Prosthetis and Orthognathodontics is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 28 August 2026
For 40 years, our editorial team has had the privilege of identifying and showcasing the products, technologies, materials, and solutions making a real impact across the dental pro
DS World Las Vegas is just around the corner—September 24 to September 26 at the MGM Grand
News 28 August 2026
(6699.HK) (“Angel”) http://www.angelaligner.com said recently that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People’s Court (Jinan City, China)
From collaborative research to exceptional patient care and education , 2025 was a year of innovation and impact at the University of Colorado Anschutz School of Dental Medicine.